首页> Neuropsychiatric disease and treatment> Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study.

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study.

导出 OA

翻译打印收藏纠错

第一作者： Masaomi,Iyo

第一单位： Department of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, Japan.

作者： Masaomi,Iyo ^[1] ; Jun,Ishigooka ^[2] ; Masatoshi,Nakamura ^[3] ; Reiko,Sakaguchi ^[4] ; Keisuke,Okamoto ^[5] ; Yongcai,Mao ^[6] ; Joyce,Tsai ^[7] ; Alison,Fitzgerald ^[8] ; Kentaro,Takai ^[9] ; Teruhiko,Higuchi ^[10]

作者单位： Department of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, Japan. ^[1] Institute of CNS Pharmacology, Tokyo, Japan. ^[2] Department of Data Science, Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan. ^[3] Department of Clinical Research, Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan. ^[4] Department of Clinical Operation, Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan. ^[5] Division of Data Science, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA. ^[6] Division of Clinical Research, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA. ^[7] Division of Clinical Operations, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA. ^[8] Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan. ^[9] Japan Depression Center, Tokyo, Japan.;National Center of Neurology and Psychiatry, Tokyo, Japan. ^[10]

关键词 antipsychotic effectiveness lurasidone open-label safety schizophrenia

DOI 10.2147/NDT.S320021

PMID 34429604

发布时间 2024-04-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交